| Name | Title | Contact Details |
|---|
Diversified Portfolio Biotechnology is a Menlo Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medical Information Technology, Inc. (MEDITECH) is engaged in developing, manufacturing and marketing of computer software products for the hospital industry. The wholly owned subsidiary of the Company is Patient Care Technologies, Inc. (PtCT).
Counsyl is a DNA testing and genetic counseling service that offers genetic screening for men, women and their children. Our philosophy is simple - focus on diseases where advanced knowledge makes a difference in health outcomes, whether it`s changing a behavior, pursuing preventative measures, or simply preparing for what lies ahead. Counsyl has screened over 750,000 patients and served over 10,000 health professionals in its modern clinical laboratory. From the purely mechanical to profoundly human, Counsyl strives to make genetic screening truly accessible to everyone. The team consists of world class engineers, scientists and clinical experts as well as a renowned engineering and scientific advisory board. Counsyl integrates sophisticated technology with custom robotic automation in its accredited medical laboratory. This focus on technology has made Counsyl a leader in helping patients and doctors communicate about medical results in real time. Its products have won the Wall Street Journal`s Innovation Award for Medicine, and have been named one of Scientific American`s "Top 10 World Changing Ideas."
Increasing Accessibility to Clinical Trials and Personalized Cancer Treatment Options. Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. Massive Bio translates the world-class oncology knowledge of the large cancer centers experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. We believe all cancer patients deserve equal access to the latest in cancer research and treatment.
To build relationships with our Members, Providers, and Partners that strengthen the delivery of healthcare in our community and promotes access to quality healthcare for children, families, and individuals.